Abstract:Background: The development of novel antineoplastic agents remains highly desirable. Objective: This study focuses on the design, synthesis, and antitumor evaluation of phenyl ureas bearing 5-fluoroindolin-2-one moiety. Methods: Three sets of phenylureas were designed and synthesized and their antiproliferative ability was measured against four human carcinoma cell lines (Hela, Eca-109, A549, and MCF-7) via MTT assay. In vivo anticancer activity was further evaluated in xenograft models of human breast cancer (MCF-7). Results: A total of twenty-one new compounds were synthesized and characterized by means of 1H and 13C NMR as well as HR-MS. Three sets of compounds (1a‒1c, 2a‒2c, and 3a‒3c) were initially constructed, and preliminary antiproliferative activities of these molecules were evaluated against Hela, Eca-109, A549 and MCF-7, highlighting the meta-substituted phenylureas (1a‒1c) as the most cytotoxic set. A series of meta-substituted phenylureas derivatives (1d‒1o) were then designed and synthesized for structure-activity relationship study. Most of the new compounds showed desirable cytotoxicity, among which compound 1g exhibited the most remarkable cytotoxic effects against the tested human cancer cells with IC50 values ranging from 1.47 to 6.79 μM. Further studies showed that compound 1g suppressed tumor growth in human breast cancer (MCF- 7) xenograft models without affecting the body weight of its recipients. Conclusion: In this study, twenty-one new compounds, containing the privileged structures of phenylurea and 5-fluoroindolin-2-one, were designed and synthesized. Subsequent structureactivity studies showed that 1g was the most bioactive antitumor agent among all tested compounds, hence a potentially promising lead compound once given further optimization.

Antitumor Agents 268. Design, Synthesis, and Mechanistic Studies of New 9-Substituted Phenanthrene-Based Tylophorine Analogues As Potent Cytotoxic Agents.

Antitumor Agents 288: Design, Synthesis, SAR, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues As Potent and Selective Antitumor Agents.

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Design, Synthesis, and Biological Evaluation of Novel 4‐phenoxypyridine Derivatives As Potential Antitumor Agents

Design, synthesis and in vitro evaluation of tylophorine derivatives as possible anti-tumor agents.

QSAR Studies and Molecular Design of Phenanthrene‐based Tylophorine Derivatives with Anticancer Activity

Antitumor Agents 295. E-ring Hydroxylated Antofine and Cryptopleurine Analogues As Antiproliferative Agents: Design, Synthesis, and Mechanistic Studies.

Design and Synthesis of New 2-Arylnaphthyridin-4-ones As Potent Antitumor Agents Targeting Tumorigenic Cell Lines

Synthesis and Antitumor Activities of Phenanthrene-Based Alkaloids.

Syntheses and Antitumor Activities of Phenylpiperazine Derivatives

Design, Synthesis and Biological Evaluation of 2-Phenoxy-N-Phenylacetamides as Novel Anticancer Agents

Design and Synthesis of 2-Phenylnaphthalenoids As Inhibitors of DNA Topoisomeraseiiα and Antitumor Agents.

Synthesis of Novel Diterpenoid Analogs with In-Vivo Antitumor Activity.

Synthesis and antiproliferative activities of novel 2-substituted-4-aminothieno[3,2-d]pyrimidine derivatives

Design, Synthesis and Biological Evaluation of N-phenylsulfonylnicotinamide Derivatives As Novel Antitumor Inhibitors.

Design, Synthesis and Antitumor Assessment of Phenylureas Bearing 5-Fluoroindolin-2-one Moiety

Design, Synthesis, and Cytotoxic Activity of Novel 7-Substituted Camptothecin Derivatives Incorporating Piperazinyl-Sulfonylamidine Moieties.

Synthesis, Biological Evaluation and Molecular Docking of Novel Phenylpyrimidine Derivatives As Potential Anticancer Agents

Synthesis and Anti-cancer Activity of 3-Substituted Benzoyl-4-substituted Phenyl-1H-pyrrole Derivatives.

Design, Synthesis and Antitumor Activity Evaluation Research of Novel 2,4,6-Substituted Pyrimidine Derivatives

Design, facile synthesis and biological evaluations of novel pyrano[3,2-a]phenazine hybrid molecules as antitumor agents.